この調査レポートは、世界のコア臨床分子診断を技術別（In situハイブリダイゼーション、ポリメラーゼ連鎖反応、シーケンシング、その他）、用途別（感染症・血液スクリーニング、遺伝子検査、がんスクリーニング、その他の用途）に、過去期間の2019年から2022年、推定年の2023年、予測期間の2024年から2029年について分析しています。
この調査レポートは、地域（南北アメリカ、ヨーロッパ、アジア太平洋（APAC）、中東アフリカ）および11か国（アメリカ、カナダ、イギリス、ドイツ、イタリア、フランス、スペイン、中国、インド、日本、オーストラリア）の詳細な分析をカバーしています。さらに、この調査レポートには、市場規模、年間成長と潜在力の分析、市場プレーヤーの競合調査、投資機会、需要予測などのデータが示されています。また、この調査研究では、市場の成長指標、抑制要因、需要と供給のリスク、その他の重要な統計にも注目し、市場の進化に関連する現在および将来の市場動向の完全な評価も行っています。
予測期間である2024年から2029年にかけて、世界のコア臨床分子診断市場は10.7%のCAGRで成長すると予測されています。コア臨床分子診断の世界市場は、2022年の49億米ドルから2029年末までに110億4,000万米ドルを創出すると予測されています。
臨床分子診断学は、感染症、癌、血液病理学、臨床化学、臨床遺伝学など幅広い用途を包含し、急速に拡大している市場です。慢性疾患の有病率の増加と、疾患の早期発見のための高度な診断ソリューションに対する需要の高まりが、市場成長の原動力となっています。
さらに、世界的な感染症の蔓延は臨床分子診断ソリューションの需要に大きく貢献しており、ポリメラーゼ連鎖反応（PCR）検査が新型コロナウイルス感染症（COVID-19）を検出するための主要な方法として浮上しています。ポリメラーゼ連鎖反応（PCR）検査の応用は、感染症の分子診断、特に核酸ベースの方法論の分野を強化する上で重要な役割を果たしています。その結果、この特定のセグメントは、コア臨床分子診断市場内で最も顕著なセグメントの 1 つとして浮上しました。
目次
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
2.1 Integration of AI and Data Analytics to deliver highly accurate and rapid results
2.2 Partnerships with Academic Institutes
3. Global Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
3.1 Age-standardised cancer incidence rate, 2020*
3.2 SARS-Cov-2 Tests: Volumes 2020
3.3 Molecular diagnostics undergoing Clinical trials
3.4 Global Core Clinical Molecular Diagnostics Market: Dashboard
3.5 Global Core Clinical Molecular Diagnostics Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on the Global Core Clinical Molecular Diagnostics Market
3.7 Global Core Clinical Molecular Diagnostics Market Segmentation: By Application
3.7.1 Global Core Clinical Molecular Diagnostics Market, By Application Overview
3.7.2 Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global Core Clinical Molecular Diagnostics Market Segmentation: By Technology
3.8.1 Global Core Clinical Molecular Diagnostics Market, By Technology Overview
3.8.2 Global Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.4 Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.5 Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
4. Global Core Clinical Molecular Diagnostics Market, Region Analysis
4.1 Regional Coverage of the Study
5. Americas Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
5.1 Americas Core Clinical Molecular Diagnostics Market: Snapshot
5.2 Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Core Clinical Molecular Diagnostics Market: Key Factors
5.4 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Application
5.4.1 Americas Core Clinical Molecular Diagnostics Market, By Application Overview
5.4.2 Americas Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.4 Americas Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.5 Americas Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Technology
5.5.1 Americas Core Clinical Molecular Diagnostics Market, By Technology Overview
5.5.2 Americas Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Country
5.6.1 United States Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.1.1 United States Core Clinical Molecular Diagnostics Market, By Application
5.6.1.2 United States Core Clinical Molecular Diagnostics Market, By Technology
5.6.2 Canada Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.2.1 Canada Core Clinical Molecular Diagnostics Market, By Application
5.6.2.2 Canada Core Clinical Molecular Diagnostics Market, By Technology
5.6.3 Rest of Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.3.1 Rest of Americas Core Clinical Molecular Diagnostics Market, By Application
5.6.3.2 Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology
6. Europe Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
6.1 Europe Core Clinical Molecular Diagnostics Market: Snapshot
6.2 Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Core Clinical Molecular Diagnostics Market: Key Factors
6.4 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Application
6.4.1 Europe Core Clinical Molecular Diagnostics Market, By Application Overview
6.4.2 Europe Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.4 Europe Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.5 Europe Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Technology
6.5.1 Europe Core Clinical Molecular Diagnostics Market, By Technology Overview
6.5.2 Europe Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Country
6.6.1 France Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.1.1 France Core Clinical Molecular Diagnostics Market, By Application
6.6.1.2 France Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 United Kingdom Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 United Kingdom Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 United Kingdom Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 Italy Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 Italy Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 Italy Core Clinical Molecular Diagnostics Market, By Technology
6.6.3 Spain Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.3.1 Spain Core Clinical Molecular Diagnostics Market, By Application
6.6.3.2 Spain Core Clinical Molecular Diagnostics Market, By Technology
6.6.4 Germany Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.4.1 Germany Core Clinical Molecular Diagnostics Market, By Application
6.6.4.2 Germany Core Clinical Molecular Diagnostics Market, By Technology
6.6.5 Rest of Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.5.1 Rest of Europe Core Clinical Molecular Diagnostics Market, By Application
6.6.5.2 Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology
7. Asia-Pacific Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
7.1 Asia-Pacific Core Clinical Molecular Diagnostics Market: Snapshot
7.2 Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia-Pacific Core Clinical Molecular Diagnostics Market: Key Factors
7.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Application
7.4.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application Overview
7.4.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Technology
7.5.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology Overview
7.5.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Country
7.6.1 China Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.1.1 China Core Clinical Molecular Diagnostics Market, By Application
7.6.1.2 China Core Clinical Molecular Diagnostics Market, By Technology
7.6.2 Japan Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.2.1 Japan Core Clinical Molecular Diagnostics Market, By Application
7.6.2.2 Japan Core Clinical Molecular Diagnostics Market, By Technology
7.6.3 India Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.3.1 India Core Clinical Molecular Diagnostics Market, By Application
7.6.3.2 India Core Clinical Molecular Diagnostics Market, By Technology
7.6.4 Australia Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.4.1 Australia Core Clinical Molecular Diagnostics Market, By Application
7.6.4.2 Australia Core Clinical Molecular Diagnostics Market, By Technology
7.6.5 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.5.1 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application
7.6.5.2 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology
8. Middle-East & Africa Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
8.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Snapshot
8.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Key Factors
8.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Application
8.4.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Application Overview
8.4.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Technology
8.5.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Technology Overview
8.5.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on Global Core Clinical Molecular Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter’s Five Forces Analysis
10.1 Porter’s Five Forces Model
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Core Clinical Molecular Diagnostics Market
11.4 Company Profiles
11.4.1 Merck Group (SigmaAldrich Co., LLC)
11.4.2 F. Hoffmann-La Roche AG
11.4.3 Agilent technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 QIAGEN
11.4.7 Thermo Fisher Scientific
11.4.8 Becton, Dickinson and Company
11.4.9 Hologic, Inc.
11.4.10 Danaher Corporation
List of Figures
Figure 1: Age-standardised cancer incidence rate, 2020*
Figure 2: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2019-2022 (USD Billion)
Figure 3: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2023-2029 (USD Billion)
Figure 4: Global Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 5: Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 6: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Infectious disease and blood screening, 2019-2029 (USD Billion)
Figure 7: Global Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 8: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Genetic testing, 2019-2029 (USD Billion)
Figure 9: Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 10: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Cancer Screening, 2019-2029 (USD Billion)
Figure 11: Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 12: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Other Applications, 2019-2029 (USD Billion)
Figure 13: Global Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 14: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By In situ hybridization, 2019-2029 (USD Billion)
Figure 15: Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 16: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Polymerase Chain Reaction, 2019-2029 (USD Billion)
Figure 17: Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 18: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Sequencing, 2019-2029 (USD Billion)
Figure 19: Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 20: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Others, 2019-2029 (USD Billion)
Figure 21: Americas Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 22: Americas Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 23: Americas Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 24: Americas Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Americas Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 26: Americas Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Americas Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 28: Americas Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 29: Americas Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 30: Americas Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: United States Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 32: United States Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 33: United States Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 34: United States Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 35: Canada Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 36: Canada Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 37: Canada Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 38: Canada Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 39: Rest of Americas Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 40: Rest of Americas Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 41: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 42: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 43: Europe Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 44: Europe Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 45: Europe Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 46: Europe Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 47: Europe Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 48: Europe Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 49: Europe Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 50: Europe Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 51: Europe Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 52: Europe Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 53: France Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 54: France Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 55: France Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 56: France Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 57: United Kingdom Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 58: United Kingdom Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 59: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 60: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 61: Italy Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 62: Italy Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 63: Italy Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 64: Italy Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 65: Spain Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 66: Spain Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 67: Spain Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 68: Spain Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 69: Germany Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 70: Germany Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 71: Germany Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 72: Germany Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 73: Rest of Europe Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 74: Rest of Europe Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 75: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 76: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 77: Asia Pacific Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 78: Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 79: Asia Pacific Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 80: Asia Pacific Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 81: Asia Pacific Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 82: Asia Pacific Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 83: Asia Pacific Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 84: Asia Pacific Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 85: Asia Pacific Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 86: Asia Pacific Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 87: China Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 88: China Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 89: China Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 90: China Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 91: Japan Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 92: Japan Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 93: Japan Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 94: Japan Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 95: India Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 96: India Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 97: India Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 98: India Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 99: Australia Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 100: Australia Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 101: Australia Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 102: Australia Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 103: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 104: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 105: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 106: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 107: Middle East and Africa Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 108: Middle East and Africa Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 109: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 110: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Middle East and Africa Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 115: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 116: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 117: Global Impact of Drivers and Restraints
Figure 118: Market Share of Prominent Companies of Core Clinical Molecular diagnostics market, 2022 (%)
Figure 119: Merck Group Revenues, 2020-2022 (USD Million)
Figure 120: Merck Group Revenues, By Geographic Segments, 2022 (%)
Figure 121: Merck Group Revenue , By Business Segments, 2022 (%)
Figure 122: Roche Revenues, 2020-2022 (USD Million)
Figure 123: Roche Revenue , By Business Segment, 2022 (%)
Figure 124: Agilent technologies Revenues, 2020-2022 (USD Million)
Figure 125: Agilent technologies Revenue , By Geographic Segment, 2022 (%)
Figure 126: Agilent technologies Revenue , By Business Segment, 2022 (%)
Figure 127: Abbott Laboratories Revenues, 2020-2022 (USD Million)
Figure 128: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
Figure 129: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
Figure 130: Qiagen Revenues, 2020-2022 (USD Million)
Figure 131: Qiagen Revenue , By Customer class , 2022 (%)
Figure 132: Qiagen Revenue , By Geographical Segments, 2022 (%)
Figure 133: Thermo Fisher Revenues, 2020-2022 (USD Million)
Figure 134: Thermo Fisher Revenue , By Geographic segment, 2022 (%)
Figure 135: Thermo Fisher Revenue , By Business Segments, 2022 (%)
Figure 136: Becton, Dickinson and Company Revenues, 2020-2022 (USD Million)
Figure 137: Becton, Dickinson and Company Revenue , By Geographic segment, 2022 (%)
Figure 138: Becton, Dickinson and Company Revenue , By Business Segments, 2022 (%)
Figure 139: Hologic Revenues, 2020-2022 (USD Million)
Figure 140: Hologic Revenue , By Business Segment, 2022 (%)
Figure 141: Hologic Revenue , By Geographical Segments, 2022 (%)
Figure 142: Danaher Revenues, 2020-2022 (USD Million)
Figure 143: Danaher Revenue , By Business Segment, 2022 (%)
Figure 144: Danaher Revenues, By Geographical Segments, 2022 (%)
List of Tables
Table A1: SARS-Cov-2 Tests: Volumes 2020
Table A2: Molecular diagnostics undergoing Clinical trials
Table A3: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A4: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A5: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A6: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A7: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A8: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A9: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A10: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A11: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A12: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A13: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A14: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A15: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A16: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A17: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A18: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A19: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A20: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A21: United Kingdom Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A22: United Kingdom Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A23: Italy Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A24: Italy Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A25: Italy Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A26: Italy Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A27: Spain Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A28: Spain Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A29: Spain Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A30: Spain Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A31: Germany Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A32: Germany Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A33: Germany Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A34: Germany Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A35: Rest of Europe Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A36: Rest of Europe Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A37: Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A38: Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A39: China Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A40: China Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A41: China Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A42: China Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A43: Japan Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A44: Japan Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A45: Japan Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A46: Japan Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A47: India Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A48: India Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A49: India Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A50: India Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A51: Australia Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A52: Australia Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A53: Australia Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A54: Australia Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A55: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A56: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A57: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A58: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A59: Merck Group. Key Financials, 2020-2022
Table A60: Roche Key Financials, 2020-2022
Table A61: Agilent technologies Key Financials, 2020-2022
Table A62: Abbott Laboratories Key Financials, 2020-2022
Table A63: Qiagen Company Financials, 2020-2022
Table A64: Key Company Financials, 2020-2022
Table A65: Becton, Dickinson and Company Key Company Financials, 2020-2022
Table A66: Hologic Company Financials, 2020-2022
Table A67: Danaher Company Financials, 2020-2022
